Parnax Lab Bilan de santé
Santé financière contrôle des critères 2/6
Parnax Lab has a total shareholder equity of ₹716.9M and total debt of ₹806.4M, which brings its debt-to-equity ratio to 112.5%. Its total assets and total liabilities are ₹1.9B and ₹1.2B respectively. Parnax Lab's EBIT is ₹184.7M making its interest coverage ratio 3.2. It has cash and short-term investments of ₹18.8M.
Informations clés
112.5%
Ratio d'endettement
₹806.39m
Dette
| Ratio de couverture des intérêts | 3.2x |
| Argent liquide | ₹18.77m |
| Fonds propres | ₹716.95m |
| Total du passif | ₹1.17b |
| Total des actifs | ₹1.89b |
Mises à jour récentes de la santé financière
Pas de mise à jour
Recent updates
Analyse de la situation financière
Passif à court terme: 506128's short term assets (₹754.3M) do not cover its short term liabilities (₹818.3M).
Passif à long terme: 506128's short term assets (₹754.3M) exceed its long term liabilities (₹352.4M).
Historique et analyse du ratio d'endettement
Niveau d'endettement: 506128's net debt to equity ratio (109.9%) is considered high.
Réduire la dette: 506128's debt to equity ratio has increased from 104.1% to 112.5% over the past 5 years.
Couverture de la dette: 506128's debt is not well covered by operating cash flow (19.7%).
Couverture des intérêts: 506128's interest payments on its debt are well covered by EBIT (3.2x coverage).